Financial statements Biovirtus Research Site W Likwidacji
Balance sheet data of BIOVIRTUS RESEARCH SITE W LIKWIDACJI
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 10 673 052,35 | 6 744 856,34 | 3 918 184,08 | 3 477 340,74 | 2 272 115,12 | 2 266 545,40 |
A. Fixed assets | 8 811 171,69 | 1 285 263,06 | 1 240 962,47 | 1 160 255,47 | 1 050 303,63 | 1 003 948,69 |
B. Current assets | 1 861 880,66 | 5 459 593,28 | 2 677 221,61 | 2 317 085,27 | 1 221 811,49 | 1 232 600,59 |
C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | - | - |
D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | - | - |
Total liabilities | 10 673 052,35 | 6 744 856,34 | 3 918 184,08 | 3 477 340,74 | 2 272 115,12 | 2 266 545,40 |
A. Equity | 9 009 208,27 | 4 935 640,90 | 2 336 396,71 | 1 951 252,48 | 597 652,13 | -240 525,45 |
B. Liabilities and provisions for liabilities | 1 663 844,08 | 1 809 215,44 | 1 581 787,37 | 596 763,00 | 1 674 462,99 | 2 507 070,85 |
I. Long-term liabilities | - | - | - | - | - | - |
II. Short-term liabilities | 983 944,24 | 1 140 836,41 | 936 163,05 | 929 325,26 | 566 838,67 | 1 046 138,05 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.